|
Health equity regional symposia: Convening local stakeholders to address health disparities in the US. |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - Pfizer |
Research Funding - Pfizer |
| |
|
Employment - Cleveland Clinic |
|
Travel, Accommodations, Expenses - NCCN |
| |
|
Consulting or Advisory Role - Apollomics; Arcus Biosciences; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Genentech/Roche; Janssen Oncology; Lilly; Merck; merus; Novartis; Pfizer; Takeda; Turning Point Therapeutics; Veracyte |
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen; AstraZeneca (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Forward (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst); Tesaro/GSK (Inst) |
| |
|
|
| |
|
|
|
Stock and Other Ownership Interests - Genentech |
| |
|
Employment - Genentech/Roche; Loyal (Biotech) (I) |
Stock and Other Ownership Interests - Genentech/Roche |
Honoraria - Massachusetts General Hospital Cancer Center |
| |
|
|
Stock and Other Ownership Interests - Roche |
|
| |
|
Employment - DaVita (I); Genentech; John Muir Medical Group (I); Kaiser Permanente (I) |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Roche |